About SentiSearch

SentiSearch’s mission is to fully exploit its exclusive license to certain neurobiology technology granted to the Company by Columbia University and the company’s own patented portfolio. Our proprietary intellectual property is based on the work of Nobel laureate Dr. Richard Axel and uniquely enables us to precisely target and manipulate insect olfactory systems.

One major consequence of our unique capability is the development of insecticides with significantly enhanced effectiveness and specificity, coupled with favorable toxicity profiles. This may have substantial implications for pest control applications, including insect-borne disease control, as well as the insect repellent and agricultural crop protection markets.

Want to know more? Visit About

Unique and Patented Scientific Process


Patented olfaction intellectual property assets and applications developed by a Nobel prize winning team of scientists at Columbia University.

Read more

Insect-borne Disease Control


Innovative solutions to improve the control of malaria and dengue fever in countries where these diseases are endemic in countries around the world.

Read more

More Effective and Less Toxic Insecticides


SentiSearch’s patented scientific process allows scientists to uniquely identify both synthetic and natural compounds that are non-harmful to both humans and animals.

Read more

Effective CropScience Methods


SentiSearch’s gene modification process applications focus on the isolation of genes that are ubiquitous among insects.  These genes have a profound effect on insect’s attraction and repulsion to plant species.

Read more

Latest news

  • Bayer CropScience, SentiSearch and Leading US Universities Enter Research Cooperation

    MONHEIM, Germany and WEST PALM BEACH, Fla., Nov. 1, 2010 /PRNewswire/ — Bayer CropScience and SentiSearch, Inc. (OTC Bulletin Board: SSRC) have entered into a two-year research agreement to cooperate in the identification of new molecules targeting odorant receptors in Continue reading »

  • Five Years In, Gauging Impact of Gates Grants

    SEATTLE — Five years ago, Bill Gates made an extraordinary offer: he invited the world’s scientists to submit ideas for tackling the biggest problems in global health, including the lack of vaccines for AIDS and malaria, the fact that most vaccines Continue reading »

  • Bill & Melinda Gates Foundation

    Five years ago, the Bill & Melinda Gates Foundation awarded $458 million to research projects aimed at creating breakthrough treatments for diseases that cause millions of deaths each year in developing countries. The results are showing promise and leading to Continue reading »

  • 8k filed 9/1/10

    “ITEM 1.01. ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. On August 31, 2010, SentiSearch, Inc. (the “Company”) entered into a Project Research and Product Development Agreement (the “Agreement”) with Bayer CropScience AG (“Bayer”), effective September 15, 2010, pursuant to which the Continue reading »

Want to read more? Visit news